Products 387867-13-2
CAS 387867-13-2 appears in our catalog under these names: Tandutinib, min. 95 %, 250 mg, Tandutinib, >95% (HPLC), Tandutinib/ 99.74% (existing batch purity), Tandutinib (MLN518), Tandutinib. Offered by: Roth, TRC, TargetMol, GLPBio, Biosynth. Available pack sizes: 250mg, 100mg, 25mg, 50mg, 200mg, 10mM (in 1ml dmso), 500mg, 10mg.
Tandutinib is an N-arylpiperazine that is piperazine in which the hydrogen attached to the nitrogen at position 1 is replaced by a 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl group, while the hydrogen attached to the nitrogen at position 4 is replaced by a (p-isopropoxyphenyl)aminocarbonyl group. Tandutinib is an inhibitor of tyrosine kinases FLT3, PDGFR and KIT. It has a role as an antineoplastic agent and an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor. It is a member of phenylureas, a member of piperidines, an aromatic ether, a member of quinazolines, a N-arylpiperazine, a N-carbamoylpiperazine and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C31H42N6O4 |
|---|---|
| Molecular weight | 562.7 g/mol |
| IUPAC name | 4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide |
| InChIKey | UXXQOJXBIDBUAC-UHFFFAOYSA-N |
| SMILES | CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5 |
Computed by PubChem (NCBI)